You are here: All Products  > GenFleet Starts Phase Ib/II Trial of CDK9 Inhibitor for Peripheral T-Cell Lymphomas

GenFleet Starts Phase Ib/II Trial of CDK9 Inhibitor for Peripheral T-Cell Lymphomas

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products